Crees findings show that weight loss is crucial to improving life expectancy in patients with PCOS, regardless of how that weight loss is achieved, but the popularity of semaglutide in our current culture makes it difficult to access due to both cost and low inventory
Eric Topol, MDs Post Two new studies zero in on the anti-inflammatory effects of the GLP-1 family of drugs, independent of weight loss, highlighting the gut-brain axis (modulating TLR response) and the gut GIP impact by Daniel Drucker and colleagues This opens up the possibility of using GLP-1 drugs in the treatment of long COVID or in conditions like schizophrenia that use the TLR pathway to activate neuroinflammation
The average weight loss over 40 weeks in the SURPASS-5 study was slightly different from the findings in the SURPASS-2 study
If this medication is considered necessary despite a history of pancreatitis, extremely close monitoring for symptoms such as persistent severe abdominal pain is essential
Again, DVT and PE data were not specifically broken out in the published SELECT results